Ananda Pharma Statistics

Total Valuation

Ananda Pharma has a market cap or net worth of GBP 9.67 million. The enterprise value is 9.22 million.

Market Cap	9.67M
Enterprise Value	9.22M

Important Dates

The last earnings date was Wednesday, October 29, 2025.

Earnings Date	Oct 29, 2025
Ex-Dividend Date	n/a

Share Statistics

Ananda Pharma has 4.30 billion shares outstanding. The number of shares has increased by 44.54% in one year.

Current Share Class	4.30B
Shares Outstanding	4.30B
Shares Change (YoY)	+44.54%
Shares Change (QoQ)	+50.77%
Owned by Insiders (%)	59.55%
Owned by Institutions (%)	6.82%
Float	1.71B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	156,017.42
PB Ratio	4.55
P/TBV Ratio	14.12
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-2.45
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.74, with a Debt / Equity ratio of 0.57.

Current Ratio	0.74
Quick Ratio	0.72
Debt / Equity	0.57
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-16.25

Financial Efficiency

Return on equity (ROE) is -304.20% and return on invested capital (ROIC) is -76.79%.

Return on Equity (ROE)	-304.20%
Return on Assets (ROA)	-54.23%
Return on Invested Capital (ROIC)	-76.79%
Return on Capital Employed (ROCE)	-164.03%
Revenue Per Employee	7
Profits Per Employee	-418,943
Employee Count	9
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -29.69% in the last 52 weeks. The beta is 0.64, so Ananda Pharma's price volatility has been lower than the market average.

Beta (5Y)	0.64
52-Week Price Change	-29.69%
50-Day Moving Average	0.27
200-Day Moving Average	0.35
Relative Strength Index (RSI)	7.16
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Ananda Pharma had revenue of GBP 62 and -3.77 million in losses. Loss per share was -0.00.

Revenue	62
Gross Profit	62
Operating Income	-3.57M
Pretax Income	-3.77M
Net Income	-3.77M
EBITDA	-3.35M
EBIT	-3.57M
Loss Per Share	-0.00

Full Income Statement

Balance Sheet

The company has 1.66 million in cash and 1.21 million in debt, giving a net cash position of 452,996 or 0.00 per share.

Cash & Cash Equivalents	1.66M
Total Debt	1.21M
Net Cash	452,996
Net Cash Per Share	0.00
Equity (Book Value)	2.13M
Book Value Per Share	0.00
Working Capital	-630,140

Full Balance Sheet

Cash Flow

Operating Cash Flow	-816,385
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-5,759,653.23%
Pretax Margin	-6,081,430.65%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Ananda Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-44.54%
Shareholder Yield	-44.54%
Earnings Yield	-38.98%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Ananda Pharma has an Altman Z-Score of -3.77 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.77
Piotroski F-Score	2